TDP1 and cancer: Furthermore, SCAN1 patients have spinocerebellar atrophy (causing ataxia that debuts in the second decade of life) but show no increase in cancer predisposition, myocardial toxicity, immunodeficiency, or other problems related to impaired DNA repair [1].